Comparative analysis of striatal FDOPA uptake in Parkinson's disease: Ratio method versus graphical approach

Journal of Nuclear Medicine

Volumn 43, Issue 10, 2002, Pages 1324-1330

  Dhawan, Vijay ^a   Ma, Yilong ^a   Pillai, Vandhana ^a   Spetsieris, Phoebe ^a   Chaly, Thomas ^a   Belakhlef, Abdelfatihe ^a   Margouleff, Claude ^a   Eidelberg, David ^a  

^a N Shore Long Isl Jewish Res Inst ^*  (United States)

Author keywords

Graphical analysis; L 3,4 dihydroxy 18F fluorophenylalanine; Parkinson's disease; PET; Ratio method

Indexed keywords

6 FLUORODOPA F 18; DOPA; FLUORINE 18;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DOPAMINERGIC SYSTEM; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MATHEMATICAL ANALYSIS; NIGRONEOSTRIATAL SYSTEM; OCCIPITAL LOBE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CORPUS STRIATUM; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; MIDDLE AGED; P-FLUOROPHENYLALANINE; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036789430     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Takikawa S, Dhawan V, Chaly T, et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J Nucl Med. 1994;35:955-963.
2. Vingerhoets FJ, Schulzer M, Ruth TJ, Holden JE, Snow BJ. Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease. J Nucl Med. 1996;37:421-426.
3. 18F]dopa PET. J Neurol Neurosurg Psychiatry. 1998;64:314-319.
4. 18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods. J Cereb Blood Flow Metab. 1993;13:57-69.
5. Ishikawa T. Dhawan V, Chaly T, et al. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease. J Nucl Med. 1996;37:216-222.
6. Ishikawa T, Dhawan V, Kazumata K, et al. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. J Nucl Med. 1996;37:1760-1765.
7. Nakamura T, Dhawan V. Chaly T, et al. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Ann Neurol. 2001;50:181-187.
8. 18F]dopa metabolism in the striatum in Parkinson's disease. Brain. 1996;19:2097-2103.
9. DeJesus OT, Endres CJ, Shelton SE, et al. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluoroDOPA. J Nucl Med. 1997;38:630-636.
10. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S. ed. Recent Developments in Parkinson's Disease. Floral Park, NJ: Macmillan; 1987:293-304.
11. Dhawan V, Kazumata K, Robeson W, et al. Quantitative brain PET: comparison of 2D and 3D acquisition on the GE Advance scanner. Clin Positron Imaging. 1998;1:135-144.
12. Vingerhoets FJ, Snow BJ, Lee CS, et al. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol. 1994;36:759-764.
13. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab. 1985;5:584-590.
14. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1-7.
15. Patlak C, Dhawan V, Takikawa S, et al. Estimation of striatal uptake rate constant of FDOPA using PET: methodological issues. In: Umera K, ed. Quantification of Brain Function: Tracer Kinetics and Image Analysis in Brain PET. Amsterdam, The Netherlands: Elsevier Science Publishers BV; 1993;263-268.
16. Brooks DJ, Salmon EP, Mathias CJ et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. Brain. 1990;113:1539-1552.